Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

Elizabeth C. Smyth, Matteo Fassan, David Cunningham, William H. Allum, Alicia F. C. Okines, Andrea Lampis, Jens C. Hahne, Massimo Rugge, Clare Peckitt, Matthew Nankivell, Ruth Langley, Michele Ghidini, Chiara Braconi, Andrew Wotherspoon, Heike I. Grabsch, Nicola Valeri

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)2721-2727
Number of pages10
JournalJournal of Clinical Oncology
Volume34
Issue number23
DOIs
Publication statusPublished - 10 Aug 2016

Keywords

  • DISEASE-SPECIFIC SURVIVAL
  • PREOPERATIVE CHEMORADIOTHERAPY
  • PERIOPERATIVE CHEMOTHERAPY
  • ESOPHAGOGASTRIC JUNCTION
  • F-18-FDG PET
  • CANCER
  • REGRESSION
  • ADENOCARCINOMA
  • ESOPHAGEAL
  • CARCINOMA

Cite this

Smyth, E. C., Fassan, M., Cunningham, D., Allum, W. H., Okines, A. F. C., Lampis, A., Hahne, J. C., Rugge, M., Peckitt, C., Nankivell, M., Langley, R., Ghidini, M., Braconi, C., Wotherspoon, A., Grabsch, H. I., & Valeri, N. (2016). Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Journal of Clinical Oncology, 34(23), 2721-2727. https://doi.org/10.1200/JCO.2015.65.7692